Announcements
Important COVID Reporting Update:
COVID-related deaths should no longer be reported under the "2019 Novel Coronavirus" condition. Providers must submit COVID death morbidity reports under the COVID-19-Associated Adult Mortality or COVID-19-Associated Pediatric Mortality condition codes, as appropriate. Please reference the condition-specific one-page document for further information.
On January 1st, 2026, updates to the Indiana Reportable Disease List for Healthcare Providers and Hospitals and the Indiana Reportable Result/Pathogen List for Laboratories went into effect. Attached below, you will find the updated reportable disease lists and the summary of changes made. If you have any questions, please contact Lunden Espinosa LEspinosa@health.in.gov and Jim Sainsbury JSainsbury@health.in.gov.
- Indiana Reportable Disease List for Healthcare Providers and Hospitals
- Indiana Reportable Result/Pathogen List for Laboratories
- Summary of Reporting Changes Document
April 15, 2024: The following resources for use in submitting Electronic Lab Reports (ELR) using the guidelines established by HL7 Messaging standards, version 2.5.1 are now available. Please contact NBS@health.in.gov with any questions.
Indiana Reportable Disease List for Healthcare Providers and Hospitals
How to Report
Step 1:
Call (317) 233-7125 (weekdays 8:15 a.m. to 4:45 p.m. EST) or (317) 233-1325 (after hours)
Step 2:
NBS Users: Report conditions via Morbidity Report in NBS
Non-NBS Users: Report via the following reporting form: Confidential Report of Communicable Diseases
- Anthrax
- Botulism
- Cholera (Vibrio cholerae O1, O139, or toxigenic)
- Diphtheria
- Influenza A, Novel
- Measles (Rubeola)
- Melioidosis (Burkholderia pseudomallei)
- Meningococcal disease, invasive
- Middle East Respiratory Syndrome (MERS‑CoV)
- New World screwworm myiasis
- Plague
- Poliomyelitis
- Primary amebic meningoencephalitis (Naegleria fowleri)
- Rabies, human
- Rubella (German Measles)
- Rubella congenital syndrome
- Severe Acute Respiratory Syndrome (SARS‑CoV)
- Smallpox (Variola infection)
- Tularemia
-
Viral hemorrhagic fever, filoviruses
- Ebola virus
- Marburg virus
-
Viral hemorrhagic fever, other
- Chapare virus
- Crimean‑Congo hemorrhagic fever virus
- Guanarito virus
- Junin virus
- Lassa virus
- Lujo virus
- Machupo virus
- Rift Valley fever virus
- Sabia virus
How to Report
NBS Users: Report conditions via Morbidity Report in NBS
Non-NBS Users: Report via the specific reporting form below:
- STIs and HIV/AIDS
- Tuberculosis (cases & suspects)
- Latent TB infection
- Animal bites
- Confidential Report for Communicable Diseases -- use for all other reportable conditions
*If you are having trouble accessing the above State Form, please try again without using a VPN, check your downloads folder, and/or use Google Chrome
- Acquired Immunodeficiency Syndrome (AIDS)
- Acute Flaccid Myelitis (AFM)
- Anaplasmosis
- Animal bite or exposure
- Arboviral disease or infection, domestic
- California serogroup viruses
- Eastern equine encephalitis virus
- Heartland virus
- Jamestown Canyon virus
- La Crosse virus
- Powassan virus
- St. Louis encephalitis virus
- West Nile virus
- Western equine encephalitis virus
- Arboviral disease or infection, imported
- Chikungunya virus
- Dengue virus
- Japanese encephalitis
- Oropouche virus
- Yellow fever
- Zika virus
- Babesiosis
- Brucellosis
- Campylobacteriosis
- Candida auris
- Carbapenemase-Producing Organisms (CPO)
- Chancroid
- Chlamydia trachomatis, genital infection
- Lymphogranuloma venereum
- Coccidioidomycosis
- COVID-19-associated deaths (all ages)
- Cronobacter infection, invasive, infants (younger than 1 year of age)
- Cryptosporidiosis
- Cyclosporiasis
- Ehrlichiosis
- Escherichia coli (E. coli) infection (Shiga toxin-producing E. coli (STEC)) including, but not limited to, E. coli O157 and other serogroups)
- Giardiasis
- Gonorrhea
- Disseminated gonococcal infection
- Haemophilus influenzae, invasive disease, (including antimicrobial susceptibility testing)
- Hansen’s disease (leprosy)
- Hantavirus pulmonary syndrome and non-pulmonary syndrome
- Hemolytic uremic syndrome (HUS), post-diarrheal
- Hepatitis, viral, Type A
- Hepatitis, viral, Type B (acute and chronic)
- Hepatitis, viral, Type B, pregnant woman or perinatally exposed infant
- Hepatitis, viral, Type C (acute and chronic)
- Hepatitis, viral, Type C, pregnant woman or perinatally exposed infant
- Hepatitis, viral, Type Delta
- Hepatitis, viral, Type E
- Hepatitis, viral, unspecified
- Histoplasmosis
- HIV infection*
- HIV infection, pregnant woman or perinatally exposed infant*
- Influenza-associated death (all ages)
- Latent tuberculosis infection (LTBI)
- Legionellosis
- Leptospirosis
- Listeriosis
- Lyme disease
- Malaria
- Mpox (formerly known as Monkeypox)
- Multisystem Inflammatory Syndrome in adults (MIS-A)
- Multisystem Inflammatory Syndrome in children (MIS-C)
- Mumps
- Pandrug-resistant Organisms
- Pertussis (whooping cough)
- Psittacosis
- Q Fever
- Rabies, postexposure prophylaxis administration
- Salmonellosis, non-typhoidal
- Shigellosis
- Spotted fever rickettsiosis, including Rocky Mountain Spotted fever
- Streptococcus pneumoniae, invasive disease (including antimicrobial susceptibility testing)
- Streptococcus, Group A, invasive disease
- Syphilis
- Syphilis, congenital (pregnant woman and/or infant)
- Tetanus
- Toxic shock syndrome (streptococcal or staphylococcal)
- Trichinellosis
- Tuberculosis disease, reportable upon suspicion
- Typhoid and paratyphoid fever, cases and carriers
- Vancomycin-resistant Staphylococcus aureus (VRSA) and Vancomycin-intermediate Staphylococcus aureus (VISA)
- Varicella (chickenpox)
- Vibriosis (non-cholera Vibrio infection)
- Yersiniosis, non-pestis
* Pursuant to 410 IAC 1-2.5, HIV infection and related laboratory results must be reported directly to the Indiana Department of Health
Indiana Reportable Result/Pathogen List for Laboratories
How to Report
For immediate reporting call: (317) 233-7125 (weekdays 8:15 a.m. to 4:45 p.m. EST) or (317) 233-1325 (after hours)
Please also report via electronic laboratory reporting.
For facilities unable to submit via ELR, please fax reports to 317-234-2812.
- Bacillus anthracis
- Burkholderia mallei
- Burkholderia pseudomallei
- Clostridium botulinum
- Cochliomyia hominivorax
- Corynebacterium diphtheriae
- Eastern equine encephalitis virus
- Francisella tularensis
- Measles virus
- Middle East Respiratory Syndrome (MERS‑CoV)
- Naegleria fowleri
- Neisseria meningitidis, invasive disease
- Novel influenza A
- Poliovirus
- Rabies virus
- Rubella virus
- Severe Acute Respiratory Syndrome (SARS‑CoV)
- Smallpox (variola) virus
- Vibrio cholerae O1, O139, or toxigenic
-
Viral hemorrhagic fever
- Ebola virus
- Marburg virus
-
Viral hemorrhagic fever, other
- Chapare virus
- Crimean‑Congo hemorrhagic fever virus
- Guanarito virus
- Junin virus
- Lassa virus
- Lujo virus
- Machupo virus
- Rift Valley fever virus
- Sabia virus
- Yersinia pestis
How to Report
Report via electronic laboratory reporting.
For facilities unable to submit via ELR, please fax reports to 317-234-2812.
- Anaplasma phagocytophilium
-
Arboviruses including, but not limited to:
- California serogroup viruses
- Chikungunya virus
- Dengue virus
- Heartland virus
- Jamestown Canyon virus
- Japanese encephalitis virus
- La Crosse virus
- Oropouche virus
- Powassan virus
- St. Louis encephalitis virus
- Western equine encephalitis virus
- West Nile virus
- Yellow fever virus
- Zika virus
- Babesia spp.
- Bordetella pertussis
- Borrelia burgdorferi
- Brucella spp.
- Campylobacter spp.
- Candida auris
- Carbapenemase‑producing Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii*
- Chlamydia psittaci
-
Chlamydia trachomatis
- Lymphogranuloma venereum (LGV) (C. trachomatis serotypes L1, L2, L3)
- Clostridium tetani
- Coccidioides spp.
- Coxiella burnetii
- Cronobacter spp., infants (under 1 year)
- Cryptosporidium spp.
- Cyclospora cayetanensis
- Ehrlichia spp.
- Escherichia coli (Shiga toxin‑producing STEC), including: O157, O157:H7, non‑O157, and Shiga toxin detected
- Giardia spp.
- Grimontia hollisae (Vibrio hollisae)
- Haemophilus ducreyi
- Haemophilus influenzae, invasive disease*
- Hantavirus, including Sin Nombre virus, Seoul virus, and other hantaviruses
- Hepatitis, viral, Type A — Anti‑HAV IgM or RNA detected
- Hepatitis, viral, Type B†
- Hepatitis, viral, Type C†
- Hepatitis, viral, Type Delta†
- Hepatitis, viral, Type E — Anti‑HEV IgM and IgG
- Hepatitis, viral, unspecified
- Histoplasma capsulatum
- HIV and related retroviruses†
- Influenza viruses
- Interferon gamma release assay (IGRA) for tuberculosis (positive results only)
- Legionella spp.
- Leptospira spp.
- Mpox (Monkeypox) virus, including: Non‑variola Orthopox virus and Orthopox virus
- Mumps virus
- Mycobacterium leprae
- Mycobacterium tuberculosis complex
- Neisseria gonorrhoeae (list anatomic site to determine if disseminated)*
- Pandrug‑resistant Organisms*
- Photobacterium damselae (Vibrio damsela)
- Plasmodium spp.
- Pneumocystis carinii (Pneumocystis pneumonia)
- Rickettsia (non‑rickettsii spp.)
- Rickettsia rickettsii
- Salmonella spp. (non‑typhoidal)*
- Salmonella serotype Paratyphi (Paratyphoid fever)*
- Salmonella serotype Typhi (Typhoid fever)*
- SARS‑CoV‑2**
- Shigella spp.*
- Streptococcus, Group A (S. pyogenes), invasive disease*
- Streptococcus pneumoniae, invasive disease*
- Treponema pallidum
- Trichinella spiralis
- Vancomycin‑resistant Staphylococcus aureus (VRSA) and Vancomycin‑intermediate Staphylococcus aureus (VISA)*
- Varicella‑zoster virus
- Vibrio spp.
- Yersinia spp. (Enterocolitica, Pseudotuberculosis)
* Include antimicrobial susceptibility testing
** Only laboratories and testing sites that submit results via electronic lab reporting (ELR)
† Further guidance on the second page of the Indiana Reportable Result/Pathogen List for Laboratories
Additional Resources
- 2015 Communicable Disease Reporting Rule
- The Indiana Reportable Disease List for Healthcare Providers and Hospitals & the Indiana Reportable Result_Pathogen List for Laboratories have been removed from the CD Rule, revised, and are now housed in separate documents. Please see current versions above.
- COVID-19 Control Measures (updated November 2024)
- 2025 Communicable Disease Reference Guide for Schools
- Local Health Department Guidance on Communicable Disease Laws (updated July 26, 2021)
- HIPAA and Public Health Letter
- HIPAA Exemption
- Requirements for Laboratory Reporting of COVID-19 Test Results
- Indiana’s Communicable Disease (CD) Rule (410 IAC)
- HL7 Lab Checklist for ELR
- Supplemental Resources for HL7 Lab Checklist
- eCR Reporting Requirements Letterhead
- LHD Capacity Priority
Page last reviewed/updated: January 2026
